Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva's Turnaround: Is It Ever Or Never?
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva shares surge after announcing global opioid settlement
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Is A Fall Imminent For Teva Stock After Its Recent Rally? | Trefis
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Will Teva Stock Rebound After A 10% Fall In A Month?
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Finds Relief In US Opioid Crisis Settlement, Updates Long-Term Objectives :: Scrip
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva sees return to growth after opioid settlement, shares jump | Reuters
